Prescription drug · UNAPPROVED DRUG OTHER
Ropidex NDC 76420-219
dexamethasone sodium phosphate, ropivacaine hydrochloride, povidine iodine · Kit · Epidural, Infiltration, Intramuscular, Intravenous, Perineural, Topical · Asclemed USA, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 76420-219-01 | 76420021901 | 1 KIT in 1 CARTON (76420-219-01) * 25 VIAL, SINGLE-DOSE in 1 CARTON (55150-197-20) / 20 mL in 1 VIAL, SINGLE-DOSE * .9 mL in 1 PACKET (67777-419-02) * 25 VIAL in 1 TRAY (63323-506-01) / 1 mL in 1 VIALMarketed from Jun 10, 2019 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Ropidex
- Generic name (nonproprietary)
- dexamethasone sodium phosphate, ropivacaine hydrochloride, povidine iodine
- Dosage form
- Kit
- Route
- Epidural, Infiltration, Intramuscular, Intravenous, Perineural, Topical
- Labeler
- Asclemed USA, Inc.
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Identifiers
- Product ID 76420-219_23b36bd4-0dbc-366a-e063-6294a90a1565SPL ID 23b36bd4-0dbc-366a-e063-6294a90a1565SPL set ID 2577c1ba-8aff-4098-ba11-a375e9ce3caaRxCUI 797730, 1734483, 1812079
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N476420021901followed by a unit qualifier and the quantityPackage 76420-0219-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE By intravenous or intramuscular injection when oral therapy is not feasible: 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance). Acute adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; mineralocorticoid supplementation may be necessary, particularly when synthetic analogs are used). Preoperatively, and in the event of serious trauma or illness, in patients with known adrenal insufficiency or when adrenocorti…
Excerpt only. Read the full label for complete information.